Tag Archive | "PAT"

IFPAC 2012: The Club Opens Up

Posted on 27 January 2012. Tags: , , , , , ,

by Agnes Shanley

 Read more...

Posted in Opinion Editorial, QbD NewsComments (0)

Case Studies: Multivariate Analysis at Novartis

Posted on 17 January 2012. Tags: , ,

The European Pharmaceutical Review recently published an article from Novartis on how it is using PAT tools and multivariate data analysis (MVDA) for statistical process control. The article by Marianna Machin, Lorenz Liesum and Antonio Peinado features background of Novartis’ PAT program, and two case studies, one each from the pharma and biopharma realms:

 Read more...

Posted in Expert Insights, ResourcesComments (0)

Pharma Faces a New Year: Will it Mirror, or Break Away From, the Past?

Posted on 29 November 2011. Tags: , , ,

By Ali Afnan, PhD, Principal, Step Change Pharma, Inc.

As this year comes to an end, it’s a good idea to take stock of the past year and look at where the pharmaceutical industry may be heading. Will the future mirror the past?

 Read more...

Posted in Expert Insights, Opinion EditorialComments (1)

Berlin Conference Discusses QbD and PAT to Ensure ROI

Posted on 14 June 2011. Tags: , ,

By Emil Ciurczak, Contributing Editor

 Read more...

Posted in QbD NewsComments (0)

Will Biopharma Dare to Be Innovative?

Posted on 07 June 2011. Tags: , , ,

By Ali Afnan, Ph.D., Principal, Step Change Pharma, Inc.

The drug industry today is suffering from a lack of innovation. If it continues along this path, only stagnation can result.

 Read more...

Posted in Expert Insights, Opinion EditorialComments (0)

Do We Need PAT and QbD Anymore?

Posted on 15 March 2011. Tags: , , ,

By Agnes Shanley

The last gasp of winter, 2011, brought  with it record snowfalls and tragic natural disasters, as well as some quiet and unheralded news that, some observers believe, may signal new competitive pressures in store for the drug industry.

 Read more...

Posted in Opinion EditorialComments (2)

Page 1 of 812345...Last »